M&T Bank’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

M&T Bank’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,480	Closed	-$466K	–	1698
2023 Q4	$466K	Buy	+7,480	New	+$186K	﹤0.01%	1150

M&T Bank's RYZB Position: Q1 2024 in Review

M&T Bank sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 7,480 shares — an estimated $466K sold.

M&T Bank first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $466K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

M&T Bank reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
M&T Bank sold 7,480 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $466K.
M&T Bank first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
M&T Bank's RayzeBio, Inc. Common Stock position peaked at $466K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on M&T Bank's 13F filing for Q1 2024, filed 7 May 2024.